BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12629266)

  • 1. An insight into the role of human pancreatic lithostathine.
    Patard L; Lallemand JY; Stoven V
    JOP; 2003 Mar; 4(2):92-103. PubMed ID: 12629266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pancreatic lithostathine inhibitor of calcium carbonate precipitation: structure-function relationship].
    Bernard JP; Takacs T; de Reggi M; Sarles H; Dagorn JC
    Nephrologie; 1993; 14(6):257-9. PubMed ID: 8145882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation.
    Bertrand JA; Pignol D; Bernard JP; Verdier JM; Dagorn JC; Fontecilla-Camps JC
    EMBO J; 1996 Jun; 15(11):2678-84. PubMed ID: 8654365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory pancreatic stone protein messenger RNA. Nucleotide sequence and expression in chronic calcifying pancreatitis.
    Giorgi D; Bernard JP; Rouquier S; Iovanna J; Sarles H; Dagorn JC
    J Clin Invest; 1989 Jul; 84(1):100-6. PubMed ID: 2525567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein inhibitors of calcium salt crystal growth in saliva, bile and pancreatic juice.
    Verdier JM; Dussol B; Berland Y; Dagorn JC
    Scanning Microsc; 1993 Sep; 7(3):1017-30. PubMed ID: 8146603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic stone protein of pancreatic calculi in chronic calcified pancreatitis in man.
    Jin CX; Naruse S; Kitagawa M; Ishiguro H; Kondo T; Hayakawa S; Hayakawa T
    JOP; 2002 Mar; 3(2):54-61. PubMed ID: 11884767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-X, Pancreatic Stone-, Pancreatic thread-, reg-protein, P19, lithostathine, and now what? Characterization, structural analysis and putative function(s) of the major non-enzymatic protein of pancreatic secretions.
    De Reggi M; Gharib B
    Curr Protein Pept Sci; 2001 Mar; 2(1):19-42. PubMed ID: 12369899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine.
    Gerbaud V; Pignol D; Loret E; Bertrand JA; Berland Y; Fontecilla-Camps JC; Canselier JP; Gabas N; Verdier JM
    J Biol Chem; 2000 Jan; 275(2):1057-64. PubMed ID: 10625646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization and preliminary crystallographic study of human lithostathine.
    Pignol D; Bertrand JA; Bernard JP; Verdier JM; Dagorn JC; Fontecilla-Camps JC
    Proteins; 1995 Dec; 23(4):604-6. PubMed ID: 8749859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
    Bimmler D; Graf R; Scheele GA; Frick TW
    J Biol Chem; 1997 Jan; 272(5):3073-82. PubMed ID: 9006958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of pancreatic stone protein.
    Hayakawa T; Naruse S; Kitagawa M; Nakae Y; Hayakawa S
    Nagoya J Med Sci; 1994 Dec; 57(3-4):109-18. PubMed ID: 7898566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pancreatic lithogenesis].
    Sarles H
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):37-40. PubMed ID: 3963739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and physiopathology of chronic pancreatitis and the role of the pancreatic stone protein.
    Sarles H
    Clin Gastroenterol; 1984 Sep; 13(3):895-912. PubMed ID: 6386244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal lithostathine: a new protein inhibitor of lithogenesis].
    Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezène P; Boistelle R; Berland Y; Dagorn JC
    Nephrologie; 1993; 14(6):261-4. PubMed ID: 8145883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of calcium binding properties of lithostathine.
    Lee BI; Mustafi D; Cho W; Nakagawa Y
    J Biol Inorg Chem; 2003 Feb; 8(3):341-7. PubMed ID: 12589570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic stone protein, a new marker for chronic pancreatitis].
    Montalto G; Carroccio A; Notarbartolo A
    Minerva Med; 1988 Feb; 79(2):91-4. PubMed ID: 3352949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic stone protein. II. Implication in stone formation during the course of chronic calcifying pancreatitis.
    Multigner L; Sarles H; Lombardo D; De Caro A
    Gastroenterology; 1985 Aug; 89(2):387-91. PubMed ID: 3924721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lithostathine S2-5: a relevant inhibitor of pancreatic stone formation?
    Bimmler D; Graf R; Frick T
    Pancreas; 1999 May; 18(4):417-8. PubMed ID: 10231850
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic stone protein: quantification in pancreatic juice by enzyme-linked immunosorbent assay and comparison with other methods.
    Provansal-Cheylan M; Mariani A; Bernard JP; Sarles H; Dupuy P
    Pancreas; 1989; 4(6):680-9. PubMed ID: 2510147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic lithostathine as a calcite habit modifier.
    Geider S; Baronnet A; Cerini C; Nitsche S; Astier JP; Michel R; Boistelle R; Berland Y; Dagorn JC; Verdier JM
    J Biol Chem; 1996 Oct; 271(42):26302-6. PubMed ID: 8824282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.